Physician profile
Alan Auerbach
NPI 1902913759
$31,494.73
in general payments reported to CMS, 2019-2025
30 companies · $84.12 in 2025
The $84.12 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $4,580 · 2021: $638 · 2022: $1,100 · 2023: $199 · 2024: $64.67 · 2025: $84.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $14,888.53 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13,439.84 | 2019-2025 | Trulance, Xifaxan |
| Abbvie INC. | $762.55 | 2019-2023 | Rinvoq |
| Takeda Pharmaceuticals U.S.A., INC. | $594.22 | 2019-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $463.26 | 2019-2022 | |
| Vivus LLC | $211.15 | 2019-2022 | |
| Ucb, INC. | $202.78 | 2019 | |
| Allergan, INC. | $171.55 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $111.87 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $85.93 | 2019-2022 | |
| Medtronic USA, INC. | $79.60 | 2020 | |
| Ferring Pharmaceuticals INC. | $60.47 | 2019 | |
| Phathom Pharmaceuticals, INC. | $50.21 | 2024 | Voquezna |
| Endo Pharmaceuticals INC. | $37.63 | 2019 | |
| Evoke Pharma, INC. | $35.77 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Romark Laboratories, Lc | $33.27 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $31.22 | 2022 | |
| Braintree Laboratories, INC. | $27.20 | 2019-2023 | Sutab |
| Celgene Corporation | $25.04 | 2022 | |
| Shionogi INC | $23.05 | 2020 | |
| Redhill Biopharma INC. | $19.57 | 2020 | |
| Exact Sciences Corporation | $18.44 | 2023 | Cologuard Collection Kit |
| Qol Medical, LLC | $17.91 | 2020 | |
| Alfasigma USA, INC. | $17.08 | 2020 | |
| Dova Pharmaceuticals | $16.70 | 2019 | |
| Shire North American Group INC | $15.74 | 2019 | |
| Ironwood Pharmaceuticals, INC | $14.87 | 2021 | |
| Phadia US INC. | $13.85 | 2021 | |
| Pfizer INC. | $13.20 | 2021 | |
| Intercept Pharmaceuticals, INC. | $12.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Auerbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.